| [1] |
Bergmann U, Funatomi H, Yokoyama M, et al. Insulin-like growth factor 1 overexpression in human pancreatic cancer:evidence for autocrine and paracrine roles[J]. Cancer Res, 1995, 55(10):2007-2011.
|
| [2] |
Stoeltzing O, Liu W, Reinmuth N, et al. Regulation of hypoxiainducible facter-1, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-Ⅰ receptor autocrine loop in human pancreatic cancer[J]. Am J Pathol, 2003, 163(3):1001-1011.
|
| [3] |
Fabry M, Cabrele C, Hoeker H, et al. Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line[J]. Peptides, 2000, 21(12):1885-1893.
|
| [4] |
Marinelli PW, Gianoulakis C, Kar S. Effects of voluntary ethanol drinking on[125I]insulin-like growth factor-Ⅰ,[125I]insulin-like growth factor-Ⅱ and[125I]insulin receptor binding in the mouse hippocampus and cerebellum[J]. Neuroscience, 2000, 98(4):687-695.
|
| [5] |
罗朝学. 131I-抗IGF-1R单抗对肝癌的放射免疫显像实验研究[D].重庆:第三军医大学,2003.
|
| [6] |
杨晓春.联合转染反义寡核苷酸治疗胰腺癌和MRI动态观测的实验研究[D].苏州:苏州大学,2006.
|
| [7] |
章斌,吴翼伟,范我.用188Re标记IGF-1类似物的方法[J].苏州大学学报:医学版,2007,27(5):722-725.
|
| [8] |
章斌,吴翼伟,范我,等. 188Re/99Tc m-IGF-1类似物的制备及与胰腺癌细胞结合实验研究[J].中华核医学杂志,2007,27(6):338-342.
|
| [9] |
Hartog H, Wesseling J, Boezen HM, et al. The insulin-like growth factor 1 receptor in cancer:Old focus, new future[J]. Eur J Cancer, 2007, 43(13):1895-1904.
|
| [10] |
Karamouzis MV, Papavassiliou AG. The IGF-1 network in lung carcinoma therapeutics[J]. Trends Mol Med, 2006,12(12):595-602.
|